Search
for
Sort by
Research 30 of 56
- Recalcitrant lichen planopilaris and frontal fibrosing alopecia responding to tildrakizumab
- Treatment of chronic alopecia areata with tildrakizumab: an open‐label pilot study
- Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Off-label dermatologic uses of IL-23 inhibitors
- A Case of Hidradenitis Suppurativa Responsive to Testosterone Replacement Therapy
- Treatment of Frontal Fibrosing Alopecia
- Poster Presentations
- Hot topics in research and patient care in Dermatology and Venereology, 2019
- Efficacy of tofacitinib in pediatric alopecia universalis
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Facial Psoriasis Log-based Area and Severity Index: A valid and reliable severity measurement method detecting improvement of facial psoriasis in clinical practice settings
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Olink proteomics analysis of scalp psoriasis reveals a cytokine storm inflammatory mainly related to bacterial-derived antigens
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Advances in dermatology research: A comprehensive literature review
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Treating Psoriasis: What Is New About Fumaric Acid Esters?
- Dermatologia e Procedimentos Estéticos Ed. XVIII
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Fallberichte
- Refractory dissecting cellulitis of the scalp treated with risankizumab: 2 case reports
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Successful treatment of rare linear lichen planopilaris with Ixekizumab